The new United States Preventive Services Task Force (USPSTF) Breast Cancer Screening Recommendations are a step in the right direction. However, the American College of Radiology (ACR) and Society of Breast Imaging (SBI) urge the USPSTF to go further to recommend annual mammography screening for all average-risk women ages 40 and older.

Getty Images


May 12, 2023 — The new United States Preventive Services Task Force (USPSTF) Breast Cancer Screening Recommendations are a step in the right direction. However, the American College of Radiology (ACR) and Society of Breast Imaging (SBI) urge the USPSTF to go further to recommend annual mammography screening for all average-risk women ages 40 and older. 

The USPSTF, ACR, SBI, American Cancer Society and others all agree that the most lives are saved with this annual approach. Medical experts should clear the confusion caused by differing recommendations and agree to recommend yearly mammography for average-risk women starting at age 40. 

Mounting evidence shows that Black and other minority women, Jewish women, and others develop and die from breast cancer prior to age 50 — or even age 40 — more often than white women. As our 2021 guidelines for average-risk women and our new (2023) guidelines for high-risk women make clear, potentially giving cancer another year to advance may particularly impact these women. 

The ACR and SBI also recommend that all women have a risk assessment by age 25, as called for in new ACR/SBI guidelines for high-risk women and discuss with their doctor whether earlier screening with mammography and/or MRI is needed. 

Involving factors such as sex assigned at birth, hormone use and surgical histories place transgender persons at increased risk for breast cancer. Biological females transitioning to male who do not undergo mastectomy remain at their previous risk for breast cancer and should continue to be screened as such.  

As outlined in current (2021) ACR/SBI recommendations for average-risk women, due to hormone use, biological males transitioning to female are at increased risk for breast cancer compared to other males and should speak with their doctor about their breast cancer risk. 

The societies also recommend that women continue screening past age 74, unless severe comorbidities limit life expectancy. 

For more information: www.acr.org 

 

Related USPSTF Screening Recommendations Content: 

Task Force Issues New Draft Recommendation Statement on Screening for Breast Cancer 

Hologic Statement on Recently Released USPSTF Breast Cancer Screening Guidelines 

 

Related Breast Density Content: 

VIDEO: Research and Advancements in Breast Imaging Technology 

VIDEO: FDA Update on the US National Density Reporting Standard - A Discussion on the Final Rule 

One on One … with Wendie Berg, MD, PhD, FACR, FSBI 

Creating Patient Equity: A Breast Density Legislative Update 

FDA Needs to Ensure that Information on Dense Breast Notifications are Clear and Understandable to all Members of the Public 

AI Provides Accurate Breast Density Classification 

VIDEO: The Impact of Breast Density Technology and Legislation 

VIDEO: Personalized Breast Screening and Breast Density 

VIDEO: Breast Cancer Awareness - Highlights of the NCoBC 2016 Conference 

Fake News: Having Dense Breast Tissue is No Big Deal 

The Manic World of Social Media and Breast Cancer: Gratitude and Grief 

 

Related Breast Imaging Content: 

Single vs. Multiple Architectural Distortion on Digital Breast Tomosynthesis 

Today's Mammography Advancements  

Digital Breast Tomosynthesis Spot Compression Clarifies Ambiguous Findings  

AI DBT Impact on Mammography Post-breast Therapy  

ImageCare Centers Unveils PINK Better Mammo Service Featuring Profound AI  

Radiologist Fatigue, Experience Affect Breast Imaging Call Backs  

Fewer Breast Cancer Cases Between Screening Rounds with 3-D Mammography 

Study Finds Racial Disparities in Access to New Mammography Technology 

American College of Radiology (ACR) Launches Contrast-Enhanced Mammography Imaging Screening Trial (CMIST) in Collaboration With GE Healthcare and the Breast Cancer Research Foundation


Related Content

Videos | Radiology Business

Find actionable insights to achieve sustainability and savings in radiology in this newest of ITN’s “One on One” video ...

Time July 30, 2024
arrow
News | Breast Imaging

July 29, 2024 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced the ...

Time July 29, 2024
arrow
News | Breast Imaging

July 29, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, announced a ...

Time July 29, 2024
arrow
News | Radiology Business

July 25, 2024 — The radiology gender gap is decreasing, but there remains work to be done, according to an editorial ...

Time July 25, 2024
arrow
Videos | Breast Imaging

Don't miss ITN's latest "One on One" video interview with AAWR Past President and American College of Radiology (ACR) ...

Time July 24, 2024
arrow
News | RSNA

July 23, 2024 — Professional registration is open for RSNA 2024, the world’s largest radiology forum. This year’s theme ...

Time July 23, 2024
arrow
News | Flat Panel Displays

July 17, 2024 — LG Electronics (LG) is accelerating its B2B medical device business, expanding its lineup of diagnostic ...

Time July 17, 2024
arrow
Feature | Imaging Technology News - ITN

Be sure to check out the latest digital edition of Imaging Technology News (ITN), featuring the Mobile C-arm Systems ...

Time July 11, 2024
arrow
News | Artificial Intelligence

July 9, 2024 — Lunit, a provider of Artificial Intelligence (AI)-powered solutions for cancer diagnostics and ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
Subscribe Now